Investigator, Pediatric Oncology Branch at NCI
Motivated by challenging questions and personal experiences, Dr. Troy McEachron's journey into pediatric oncology began with a pivotal realization: children are not just small adults, and their diseases require unique approaches. Now focusing on osteosarcoma, the most common bone tumor in young patients, he's dedicated to improving patient outcomes and increasing patient participation in clinical and biomedical research.
Data sharing is crucial to this work. "Sharing data allows us to transcend limitations of individual research efforts," Troy said. "By pooling our collective knowledge, we gain a more comprehensive understanding of the disease landscape."
Troy emphasized that data sharing extends beyond collaboration—it’s significant in shaping the future of pediatric oncology, and he sees data as the cornerstone of progress in understanding and treating childhood cancers. It's Troy's hope that this approach will reveal both common and unique disease mechanisms across different childhood cancers, and that these data will be used to come up with the best and most effective treatment strategies.
Outside the lab, Troy enjoys photography, balancing long-term research with moments of instant gratification.